Back
Ryde Group Ltd. Vs. Neurocrine Biosciences, Inc. Sector Stock Comparison
Sell
37
RYDE
Ryde Group Ltd.
Last Price:
$0.33
Seasonality Move:
-15.94%
Buy
66
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$146.95
Seasonality Move:
4.8%
Sell
37
Ryde Group Ltd. (RYDE)
is a Sell
Is Ryde Group Ltd. a Buy, Sell or Hold?
-
The current Ryde Group Ltd. [RYDE] share price is $0.34. The Score for RYDE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
RYDE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy, Sell or Hold?
-
The current Neurocrine Biosciences, Inc. [NBIX] share price is $146.93. The Score for NBIX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYDE Stock Price Chart
What is Ryde Group Ltd.'s stock price today?
-
The Ryde Group Ltd. share price today is $0.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYDE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIX Stock Price Chart
What is Neurocrine Biosciences, Inc.'s stock price today?
-
The Neurocrine Biosciences, Inc. share price today is $146.93The current trend is relatively stagnant and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
RYDE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 34.49 | Sell |
| Chaikin Money Flow: | 7947 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.51) | Sell |
| Bollinger Bands (100): | (0.33 - 0.51) | Sell |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | -203719 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.13 - 154.37) | Sell |
| Bollinger Bands (100): | (134.9 - 149.28) | Buy |
RYDE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Sell |
| 20-day SMA: | 0.44 | Sell |
| 50-day SMA: | 0.48 | Sell |
| 200-day SMA: | 0.34 | Sell |
| 8-day EMA: | 0.25 | Buy |
| 20-day EMA: | 0.14 | Buy |
| 50-day EMA: | 0.06 | Buy |
| 200-day EMA: | 0.02 | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 146.64 | Buy |
| 20-day SMA: | 150.75 | Sell |
| 50-day SMA: | 146.48 | Buy |
| 200-day SMA: | 130.24 | Buy |
| 8-day EMA: | 147.37 | Sell |
| 20-day EMA: | 148.33 | Sell |
| 50-day EMA: | 146.4 | Buy |
| 200-day EMA: | 136.43 | Buy |
Ryde Group Ltd. Earnings Growth & RYDE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Neurocrine Biosciences, Inc. Earnings Growth & NBIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $2.26 per share.
Ryde Group Ltd. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||